§01 Browse › CJC-1295

CJC-1295

CJC-1295 DAC Modified GRF 1-29
Research Compound
Growth hormone Recovery

This profile covers CJC-1295. Start with the peptide's intended use, human evidence and product-quality limitations before the mechanism details.

Technical catalog description

CJC-1295 is an analog of growth-hormone-releasing hormone engineered with a Drug-Affinity Complex (DAC) that dramatically extends its biological half-life from minutes to days.

When paired with a GHRP such as GHRP-2 or Ipamorelin, it creates large, physiologically-shaped GH pulses that enhance body composition, accelerate recovery and deliver noticeable anti-aging benefits.

Overview Use context Comparison Safety
Warning
Works best when combined with GHRPs · Expensive compound requiring proper storage · May cause injection site reactions

Read next

Overview

CJC-1295 only makes sense once the user understands that “CJC” often refers to two different practical products. DAC versions are long acting and change baseline signaling across days. Mod-GRF 1-29 without DAC behaves more like a short GHRH pulse tool. Users who blur those together usually end up talking past the actual pharmacology.

In practice, CJC is rarely the whole story. It is usually paired with a GHRP such as Ipamorelin or GHRP-2 because the combination amplifies GH pulses more convincingly than either side alone. That pairing is the reason it has held attention for so long.

Safety & monitoring
Side effects
  • Water retention, injection-site irritation, and variable response quality

  • False confidence from long action despite modest real-world output when used solo

Monitoring
  • fasting glucose if stacked heavily

  • bodyweight and edema

Avoid if
  • Users who do not understand DAC vs non-DAC timing differences

  • Anyone expecting large results from solo use without adjusting expectations

Use context

Users choose CJC-1295 when they want the GHRH side of the equation and a more “physiologic” story than direct hGH injection. It appeals to people who care about pulse architecture, even if the real-world result is still heavily dependent on product quality and consistent handling.

Timeline & expectations

Unverified community-use description: DAC and non-DAC products are discussed with different schedules. These accounts do not establish a formulation-specific administration frequency or outcome timeline here.

Common mistakes

The biggest mistake is talking about CJC-1295 as if DAC and Mod-GRF are interchangeable. The second is expecting solo CJC to feel like direct growth hormone. For most users it is more of a supporting signal than a dramatic stand-alone compound.

Comparison notes

Compared with Ipamorelin or GHRP-2, CJC is more like the framework than the spotlight. Compared with hGH, it offers a cleaner theoretical story with a much less predictable practical result.

Record quantities in the builder Read: Intro to Peptides ← Browse